- Advances in immunotherapy of melanoma2016 | Publication without faculty affiliation
- Immunotherapy for metastatic melanoma2015 | Publication without faculty affiliation
- New trends in immunotherapy of melanoma2020 | First Faculty of Medicine
- Radiotherapy and immunotherapy are irreplaceable in the treatment of cancer2020 | Faculty of Medicine in Hradec Králové
- IIpilimumab in the treatment of melanoma2014 | Third Faculty of Medicine
- Pembrolizumab v terapii slizničního melanomu2016 | First Faculty of Medicine
- Imunoterapie a molekulárně cílená léčba u maligního melanomu2022 | First Faculty of Medicine
- Adverse Effects of Modern Treatment of Malignant Melanoma and their Treatment/Management2014 | Faculty of Medicine in Hradec Králové
- News in immunotherapy of dMMR/MSI-H CRC2022 | Third Faculty of Medicine
- Biologická léčba melanomu2016 | Publication without faculty affiliation
- The Abscopal Effect in the Era of Checkpoint Inhibitors2021 | First Faculty of Medicine
- Combination of nivolumab and relatlimab – a new option in the treatment of malignant melanoma2023 | Faculty of Medicine in Hradec Králové
- Novel Treatment Options in Metastatic Esophageal Carcinoma: Checkpoint Inhibitors in Combination Therapies2023 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Advances in the treatment of metastatic melanoma2018 | First Faculty of Medicine
- Melanom - současné a budoucí trendy léčby2017 | Publication without faculty affiliation
- Comments on the Clinical Development of Ipilimumab2013 | Publication without faculty affiliation
- Pembrolizumab in pretreated patient2018 | Faculty of Medicine in Hradec Králové
- Immunotherapy of Renal Cell Carcinoma2017 | First Faculty of Medicine
- Nivolumab plus chemotherapy or ipilimumab in the first-line palliative therapy of esophageal, gastroesophageal junction, and gastric cancer2023 | Faculty of Medicine in Hradec Králové
- Immunotherapeutic options for treatment of malignant melanoma2019 | First Faculty of Medicine
- Možnosti využití nivolumabu v imunoterapii melanomu2022 | First Faculty of Medicine
- New potential checkpoint inhibitors in cancer therapy2022 | Faculty of Medicine in Hradec Králové
- Kompletní remise metastáz melanomu po kombinované léčbě ipilimumabem a nivolumabem u pacientky s hypofyzitidou vyvolanou imunoterapií2021 | First Faculty of Medicine
- Immunotherapy of malignant melanoma2015 | Publication without faculty affiliation
- State of the art and perspectives of Small cell lung cancer treatment2016 | Faculty of Medicine in Pilsen
- Small-cell lung cancer: epidemiology, diagnostics and therapy2017 | Faculty of Medicine in Pilsen
- CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade2021 | Faculty of Science
